Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghavendra Gowda

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|August 11, 2006
Anticoagulant effect of Naja naja venom 5'nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acidB L Dhananjaya, A Nataraju, R Rajesh, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Experimental Parasitology|May 19, 2015
A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activityMaralinganadoddi P Sadashiva, Raghavendra Gowda, Xianzhu Wu, et al.
Oncotarget|April 21, 2017
Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transportRaghavendra Gowda, Gajanan S Inamdar, Omer Kuzu, et al.
Molecular and Cellular Biochemistry|December 1, 2005
Strong myotoxic activity of Trimeresurus malabaricus venom: role of metalloproteasesC D Raghavendra Gowda, R Rajesh, A Nataraju, et al.
Molecular Cancer Therapeutics|November 23, 2019
Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma AgentSaketh S Dinavahi, Raghavendra Gowda, Krishne Gowda, et al.
Current Topics in Medicinal Chemistry|June 21, 2011
Characterization of major zinc containing myonecrotic and procoagulant metalloprotease 'malabarin' from non lethal trimeresurus malabaricus snake venom with thrombin like activity: its neutralization by chelating agentsC D Raghavendra Gowda, H V Shivaprasad, R Venkatesh Kumar, et al.
European Journal of Medicinal Chemistry|December 31, 2019
Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agentsSaketh S Dinavahi, Raghavendra Gowda, Christopher G Bazewicz, et al.
International Journal of Molecular Sciences|April 12, 2022
Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour DevelopmentSaketh S Dinavahi, Yu-Chi Chen, Raghavendra Gowda, et al.
Oncoimmunology|February 5, 2019
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunityKathleen M Kokolus, Jeremy S Haley, Emily J Koubek, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Toxicon : Official Journal of the International Society on Toxinology|August 11, 2006
Anticoagulant effect of Naja naja venom 5'nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acidB L Dhananjaya, A Nataraju, R Rajesh, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Experimental Parasitology|May 19, 2015
A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activityMaralinganadoddi P Sadashiva, Raghavendra Gowda, Xianzhu Wu, et al.
Oncotarget|April 21, 2017
Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transportRaghavendra Gowda, Gajanan S Inamdar, Omer Kuzu, et al.
Molecular and Cellular Biochemistry|December 1, 2005
Strong myotoxic activity of Trimeresurus malabaricus venom: role of metalloproteasesC D Raghavendra Gowda, R Rajesh, A Nataraju, et al.
Molecular Cancer Therapeutics|November 23, 2019
Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma AgentSaketh S Dinavahi, Raghavendra Gowda, Krishne Gowda, et al.
Current Topics in Medicinal Chemistry|June 21, 2011
Characterization of major zinc containing myonecrotic and procoagulant metalloprotease 'malabarin' from non lethal trimeresurus malabaricus snake venom with thrombin like activity: its neutralization by chelating agentsC D Raghavendra Gowda, H V Shivaprasad, R Venkatesh Kumar, et al.
European Journal of Medicinal Chemistry|December 31, 2019
Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agentsSaketh S Dinavahi, Raghavendra Gowda, Christopher G Bazewicz, et al.
International Journal of Molecular Sciences|April 12, 2022
Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour DevelopmentSaketh S Dinavahi, Yu-Chi Chen, Raghavendra Gowda, et al.
Oncoimmunology|February 5, 2019
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunityKathleen M Kokolus, Jeremy S Haley, Emily J Koubek, et al.
Pageof 5